Evidence map›Paper›PMID 35325179›Full record

ArticleNucleic acids research2022

Stitchr: stitching coding TCR nucleotide sequences from V/J/CDR3 information.

James M Heather, Matthew J Spindler, Marta Herrero Alonso, Yifang Ivana Shui, David G Millar, David S Johnson, Mark Cobbold, Aaron N Hata

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Ensembles ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Coincident epithelial signals restrain commensal-specific CD8αβbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

James M HeatherMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.ORCID 0000-0002-1783-5181
Matthew J SpindlerGigaMune, Inc., South San Francisco, CA, USA.
Marta Herrero AlonsoMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.ORCID 0000-0001-8030-6007
Yifang Ivana ShuiMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.
David G MillarMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.ORCID 0000-0002-0104-9303
David S JohnsonGigaMune, Inc., South San Francisco, CA, USA.
Mark CobboldMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.
Aaron N HataMassachusetts General Hospital Cancer Center, Charlestown, MA, USA.ORCID 0000-0002-6127-318X
Harvard University · USGigaGen (United States) · USMassachusetts General Hospital · US

Funding

Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase InhibitorsR01CA164273 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Aaron N Hata, Jessica Jiyeong Lin · 2012 to 2026
$5.5M
Recombinant TIL Cell Therapy for Salvage Solid Tumor PatientsR43CA232942 · NCI · GIGAMUNE, INC. · PI SPINDLER, MATTHEW JAMES · 2018 to 2018
$300k
Commercialization of an Advanced Technology for T Cell Receptor Analysis and EngineeringR43AI120313 · NIAID · GIGAGEN, INC. · PI JOHNSON, DAVID SCOTT · 2015 to 2016
$265k
NCI NIH HHS R01 CA164273NCI NIH HHS R43 CA232942NIAID NIH HHS R43 AI120313
6 · The paper itself

Abstract

The study and manipulation of T cell receptors (TCRs) is central to multiple fields across basic and translational immunology research. Produced by V(D)J recombination, TCRs are often only recorded in the literature and data repositories as a combination of their V and J gene symbols, plus their hypervariable CDR3 amino acid sequence. However, numerous applications require full-length coding nucleotide sequences. Here we present Stitchr, a software tool developed to specifically address this limitation. Given minimal V/J/CDR3 information, Stitchr produces complete coding sequences representing a fully spliced TCR cDNA. Due to its modular design, Stitchr can be used for TCR engineering using either published germline or novel/modified variable and constant region sequences. Sequences produced by Stitchr were validated by synthesizing and transducing TCR sequences into Jurkat cells, recapitulating the expected antigen specificity of the parental TCR. Using a companion script, Thimble, we demonstrate that Stitchr can process a million TCRs in under ten minutes using a standard desktop personal computer. By systematizing the production and modification of TCR sequences, we propose that Stitchr will increase the speed, repeatability, and reproducibility of TCR research. Stitchr is available on GitHub.

Indexed as

Receptors, Antigen, T-CellSoftwareAmino Acid SequenceBase SequenceDNA, ComplementaryHumansReproducibility of ResultsDNA, ComplementaryReceptors, Antigen, T-Cell

Identifiers

PMID35325179
PMCPMC9262623
OpenAlexW4220974185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.